Skip to content
An Initiative of AVAC
Search
Back to Country Data

Country Overview:
Tanzania

Global PrEP Tracker
Last Updated: 19 June 2025

Drug Registration Status

Approved
Pending
Not
Approved
Lenacapavir (LEN) for PrEP — Gilead
Data Not Available
Cabotegravir (CAB) for PrEP — ViiV
Approved 2024 2024
Dapivirine Vaginal Ring (DVR) — Pop Council
Under Review
Oral PrEP TDF/xTC* — Gilead (Truvada)
Approved 2016 2016
Oral PrEP TDF/xTC — generic
Approved N/A N/A
Oral PrEP F/TAF — Gilead
Not Approved
* TDF/xTC refers to tenofovir disoproxil fumarate (TDF) and either emtricitabine (FTC) or lamivudine (3TC)

Research, Demonstration and Implementation

Oral PrEP

4 Completed Projects

Dapivirine Vaginal Ring

N/A Planned/Ongoing Projects

Injectable PrEP

N/A Planned/Ongoing Projects

Policy Frameworks

Tanzania National HIV/AIDS Guidelines, 2019

National Guidelines for Comprehensive Package of HIV Interventions for Key & Vulnerable Populations, 2017

Est. Cumulative
Initiations:

Total PrEP: 462,358

Oral PrEP: 462,358

Dapivirine Vaginal Ring: N/A

Injectable PrEP: N/A

Featured Resources

Document

Tanzania Strategic Direction Summary, 2023

PEPFAR/Tanzania (PEPFAR/T) has an unprecedented and unique opportunity to utilize multiple updated national data sources to formulate a robust Country Operational Plan 2023 (COP23). COP23 planning was informed by preliminary unweighted key results from the Tanzania HIV Impact Survey (THIS) 2022-2023, Bio-Behavioral Survey 2022 (BBS 2022), 2022 Tanzania Demographic Health Survey, Malaria Indicator Survey (2022…
Document

Tanzania HIV/AIDS Monitoring & Evaluation Plan, 2017-2022

Tanzania’s M&E Plan guides key stakeholders on how to monitor and evaluate implementation of the Health Sector HIV and AIDS Strategic Plan. This includes provision of the definition of indicators to be used to report relevant results, sources of data, frequency of data collection, targets for each indicator, and institutions that are responsible for collecting…
Document

Dapivirine Ring Early Introduction Considerations — Tanzania Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Tanzania was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For…
Document

Tanzania’s Healthcare Worker Guide for Adolescent HIV Services, 2018

HIV impacts millions of adolescents and young people across the world, yet very few get the care they need to prevent or treat HIV. With a global strategy in place to end the HIV epidemic by 2030, Tanzania has made it priority to get adolescents the care they need. This is the second part of…
View All Resources